Pittsburgh, PA, United States of America

Matthew G LaPorte

USPTO Granted Patents = 7 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
7 patents (USPTO):

Title: The Innovative Mind of Matthew G. LaPorte: Advancements in Modulating p97 ATPase Activity

Introduction: Matthew G. LaPorte is a distinguished inventor based in Pittsburgh, PA, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, LaPorte focuses on developing innovative methods and compounds aimed at treating serious health conditions, including cancer and neurodegenerative disorders.

Latest Patents: LaPorte's latest inventions revolve around the modulation of p97 AAA ATPase activity. One of his notable patents, titled "Modulators of p97 AAA ATPase Activity," details methods for inhibiting or modulating p97 using specific compounds and compositions. These innovations hold promise for treating various diseases, such as antibacterial and antiviral infections, cancer, and neurodegenerative disorders that can benefit from p97 inhibition or modulation. Another significant patent, "Phenyl Indole Allosteric Inhibitors of P97 ATPase," also focuses on methods to inhibit p97 and highlights potential applications in cancer treatment and addressing neurodegenerative conditions susceptible to p97 inhibition.

Career Highlights: LaPorte's career has been marked by his work at prominent institutions, including the University of Pittsburgh and the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. His contributions in these roles have enabled the advancement of crucial biotechnological research and therapeutic developments.

Collaborations: Throughout his career, LaPorte has collaborated with esteemed colleagues such as Donna Mary Huryn and Peter Wipf. These partnerships have further enriched his research endeavors and fostered innovations that may lead to impactful medical solutions.

Conclusion: Matthew G. LaPorte stands as a notable figure in the realm of biotechnology innovation. His dedicated work on p97 ATPase activity modulation exemplifies the potential of inventive thought to drive forward breakthroughs in treating pressing health challenges. As he continues to develop ground-breaking solutions, LaPorte remains a significant contributor to the field and an inspiration to fellow inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…